XML 37 R28.htm IDEA: XBRL DOCUMENT
v3.24.3

Net Loss Per Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Net Loss Per Share |
Schedule of basic and diluted net loss per share | Basic and diluted net loss per share for the three and nine months ended September 30, 2024 and 2023 was calculated as follows (in thousands except share and per share amounts).
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, | ​ | Nine Months Ended September 30,
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023
Numerator: |  | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |
Net loss | ​ | $ | (18,176) | ​ | $ | (13,696) | ​ | $ | (52,124) | ​ | $ | (68,949)
Dividend attributable to down round feature of warrants | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (234) | ​ | ​ | —
Net loss attributable to common stockholders for basic and diluted loss per share | ​ | $ | (18,176) | ​ | $ | (13,696) | ​ | $ | (52,358) | ​ | $ | (68,949)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Denominator: | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Weighted average number of common shares outstanding – basic and diluted | ​ |  | 41,209,639 | ​ |  | 26,987,182 | ​ |  | 36,307,890 | ​ |  | 18,240,455
Net loss per share attributable to common stockholders – basic and diluted | ​ | $ | (0.44) | ​ | $ | (0.51) | ​ | $ | (1.44) | ​ | $ | (3.78)
​
Schedule of potentially anti-dilutive securities excluded from calculation of diluted net loss per share | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, | ​ | Nine Months Ended September 30,
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023
Restricted stock units to purchase common stock | ​ | 227,500 | ​ | 285,000 | ​ | 227,500 | ​ | 285,000
Options to purchase common stock |  | 4,846,635 | ​ | 3,425,647 | ​ | 4,846,635 | ​ | 3,425,647
Warrants to purchase common stock | ​ | 3,586,373 | ​ | 3,586,371 | ​ | 3,586,373 | ​ | 3,586,371
​ |  | 8,660,508 | ​ | 7,297,018 | ​ | 8,660,508 | ​ | 7,297,018
​

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration